Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.28	22.85	21.61	28.79	53.08	-
Cash & Short-Term Investments	19.28	22.85	21.61	28.79	53.08	-
Cash Growth	-40.45%	5.75%	-24.94%	-45.76%	-	-
Prepaid Expenses	0.56	0.73	0.91	1.37	3.51	-
Total Current Assets	19.83	23.58	22.52	30.15	56.58	-
Property, Plant & Equipment	0.08	0.08	0.09	0	0.21	-
Other Long-Term Assets	0.31	0.32	0.04	-	0.03	-
Total Assets	20.22	23.98	22.65	30.16	56.82	-
Accounts Payable	1.28	1.35	1.67	0.84	1.77	-
Accrued Expenses	2.08	2.01	2.19	2.36	5.35	-
Current Portion of Leases	-	-	-	-	0.19	-
Current Unearned Revenue	-	-	0.53	-	-	-
Total Current Liabilities	3.36	3.36	4.39	3.2	7.32	-
Total Liabilities	3.36	3.36	4.39	3.2	7.32	-
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	351.15	350.97	335.64	330.06	241	-
Retained Earnings	-324.97	-321.04	-308.08	-293.8	-181.13	-
Comprehensive Income & Other	-10.63	-10.63	-10.61	-10.62	-10.36	-
Total Common Equity	15.55	19.31	16.95	25.64	49.51	-
Shareholders' Equity	16.86	20.62	18.26	26.95	49.51	-
Total Liabilities & Equity	20.22	23.98	22.65	30.16	56.82	-
Total Debt	-	-	-	-	0.19	-
Net Cash (Debt)	19.28	22.85	21.61	28.79	52.89	-
Net Cash Growth	-40.45%	5.75%	-24.94%	-45.57%	-	-
Net Cash Per Share	3.23	4.15	5.97	17.37	49.69	-
Filing Date Shares Outstanding	5.53	5.49	5.43	3.73	1.06	1.06
Total Common Shares Outstanding	5.51	5.48	3.74	2.66	1.06	1.06
Working Capital	16.47	20.22	18.14	26.95	49.27	-
Book Value Per Share	2.82	3.52	4.54	9.66	45.97	-
Tangible Book Value	15.55	19.31	16.95	25.64	49.51	-
Tangible Book Value Per Share	2.82	3.52	4.54	9.66	45.97	-
Machinery	-	0.15	0.14	0.05	0.14	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q